Beta Bionics, Inc.
BBNX
$22.26
$1.778.64%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -39.06% | -- | -- | -- | |
| Total Depreciation and Amortization | 6.12% | -- | -- | -- | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 17.37% | -- | -- | -- | |
| Change in Net Operating Assets | -37.88% | -- | -- | -- | |
| Cash from Operations | -55.71% | -- | -- | -- | |
| Capital Expenditure | -118.03% | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -100.00% | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -247.79% | -- | -- | -- | |
| Cash from Investing | -245.38% | -- | -- | -- | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 782,118.52% | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -2,257.98% | -- | -- | -- | |
| Cash from Financing | 291,461.96% | -- | -- | -- | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 119.66% | -- | -- | -- | |